References

IJMABHR

International Journal of Medical and All Body Health Research

IJMABHR

2582-8940

Anfo Publication House

180

Is Covid-19 severe in patients with Alzheimer's disease?

Mirzaei

Mohaddeseh

1MSc in Geriatric Nursing, University of Social Welfare and Rehabilitation Sciences (USWR), Tehran, Iran

2023

4 2 53 56 22052023 10062023

CC BY-NC-SA 4.0

Alzheimer's disease (AD), as a degenerative neurodegenerative disease that has a growing trend causes the exacerbation of the infectious disease of COVID-19, or on the contrary, the infection of Covid-19 can aggravate the symptoms of AD and the severe form of COVID-19 appears. There are several mechanisms for the worsening of AD condition after COVID-19. It is reasonable to assume that COVID-19 has a more severe impact on patients with comorbidities, including those with AD. As such, individuals with AD should take additional preventive measures to avoid contracting COVID-19, as they are at a heightened risk of developing severe symptoms of the disease, which could result in increased mortality rates.

Alzheimer's diseaseCOVID-19SARS-CoV-2Infection

References 1

Mehta RI, Schneider JA. What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia. Current opinion in neurology. 2021; 34(2):237-45.

Armstrong RA. What causes Alzheimer’s disease?. Folia Neuropathologica. 2013; 51(3):169-88.

Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer's & Dementia. 2011; 7(5):532-9.

Rosenberg PB, Nowrangi MA, Lyketsos CG. Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?. Molecular aspects of medicine. 2015; 43:25-37.

Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019. Frontiers in Aging Neuroscience. 2022; 14:937486.

Zhang E. Alzheimer's Disease: Why is Early Detection Important?. Journal of Student Research, 2023, 12(2).

Zeisel J. Environmental design effects on Alzheimer symptoms in long-term care residences. World hospitals and health services: the official journal of the International Hospital Federation. 2000; 36(3):27-31.

Tabatabaii SA, Soltani P, Khanbabaee G, Sharma D, Valizadeh R, Farahbakhsh N, Tariverdi M, Pourghasem M, Tabiei E. SARS Coronavirus 2, severe acute respiratory syndrome, and middle east respiratory syndrome in children: A review on epidemiology, clinical presentation, and diagnosis. Archives of Pediatric Infectious Diseases. 2020; 8(4):1-8.

Mirshamsi M, Ghiasi N, Heidari S, Hosseinpour P, Hassanlouei B, Hashemipour SM, Aidenloo NS, Valizadeh R. Conjunctivitis and other ocular manifestation following Covid-19; updated information about transmission of Covid-19 by eye. Immunopathologia Persa. 2021; 7(2):e28.

Dadashzadeh N, Farshid S, Valizadeh R, Nanbakhsh M, Rahimi MM. Acute respiratory distress syndrome in COVID-19. Immunopathologia Persa. 2020; 6(2):e16.

Besharat S, Alamda NM, Dadashzadeh N, Talaie R, Mousavi SS, Barzegar A, Tavana S, Valizadeh R, Frouzesh M. Clinical and demographic characteristics of patients with COVID-19 who died in Modarres hospital. Open Access Macedonian Journal of Medical Sciences. 2020; 8(T1):144-9.

Mohamad Rahimi M, Jahantabi E, Lotfi B, Forouzesh M, Valizadeh R, Farshid S. Renal and liver injury following the treatment of COVID-19 by remdesivir. Journal of Nephropathology. 2021; 10(2):1-4.

Ciaccio M, Lo Sasso B, Scazzone C, Gambino CM, Ciaccio AM, Bivona G, Piccoli T, Giglio RV, Agnello L. COVID-19 and Alzheimer’s disease. Brain sciences. 2021; 11(3):305.

de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S, CNS SARS‐CoV‐2 Consortium. The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning. Alzheimer's & Dementia. 2021; 17(6):1056-65.

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020; 396(10248):413-46.

Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, Bianchetti L, Trabucchi M. Clinical presentation of COVID19 in dementia patients. The journal of nutrition, health & aging. 2020; 24:560-2.

Mohammadkhanizadeh A, Karimzadeh F. COVID-19 and Alzheimer's Disease: A Review of Mechanisms and Pathophysiology. Shefaye Khatam 2021; 9(2):151-159.

Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain research bulletin. 2012; 87(1): 10-20.

CarePort Health. Covid-19 report. https://careporthealth.com/wp-content/uploads/2020/05/COVID-19-Report-3.pdf. Date accessed: July 10, 2020.

D'Adamo H, Yoshikawa T, Ouslander JG. Coronavirus disease 2019 in geriatrics and long‐term care: the International Journal of Medical and All Body Health Research www.allmedicaljournal.com ABCDs of Covid‐19. Journal of the American Geriatrics Society. 2020; 68(5):912-7.